A strange thing happens during roaring bull markets. When the economy and stock market are booming, investors seem to forget the fundamentals of stock picking. With nearly every stock being carried higher as the major indexes break record after record, investors think that value no longer matters.
But nothing could be further from the truth. Using fundamentals to locate value stocks works in any type of market. While it is more difficult to locate value during times of extreme bullishness, the extra effort can pay off in spades.
Even in the most overstretched market, value cases still exist. Sometimes a company or industry falls out of favor for no apparent reason. A weak quarterly earnings report or an external event can depress a company's stock price for a short time, creating an opportunity for sharp investors.
Here are seven signs a stock could be undervalued.
1. The Current Ratio
The current ratio is simply a company's current assets divided by its current liabilities. Value investors should look for a current ratio over 1.50. This assures that the company has enough assets to survive even when bear markets rear their ugly heads.
Best Undervalued Stocks To Buy For 2019: Internationa Flavors & Fragrances, Inc.(IFF)
Advisors' Opinion:- [By Shane Hupp]
Get a free copy of the Zacks research report on International Flavors & Fragrances (IFF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Maxx Chatsko]
That would lead investors to companies such as Autodesk (NASDAQ:ADSK), International Flavors & Fragrances (NYSE:IFF), and DowDuPont (NYSE:DWDP).
- [By Max Byerly]
Get a free copy of the Zacks research report on International Flavors & Fragrances (IFF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Best Undervalued Stocks To Buy For 2019: First Midwest Bancorp, Inc.(FMBI)
Advisors' Opinion:- [By Joseph Griffin]
Bancorp Bank (NASDAQ: TBBK) and First Midwest Bancorp (NASDAQ:FMBI) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.
- [By Logan Wallace]
First Midwest Bancorp (NASDAQ:FMBI) reached a new 52-week high and low during mid-day trading on Tuesday . The company traded as low as $26.92 and last traded at $26.74, with a volume of 58961 shares trading hands. The stock had previously closed at $26.22.
- [By Joseph Griffin]
Schwab Charles Investment Management Inc. increased its holdings in First Midwest Bancorp Inc (NASDAQ:FMBI) by 5.6% during the second quarter, Holdings Channel reports. The fund owned 622,052 shares of the financial services provider’s stock after acquiring an additional 32,814 shares during the quarter. Schwab Charles Investment Management Inc.’s holdings in First Midwest Bancorp were worth $15,844,000 as of its most recent SEC filing.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on First Midwest Bancorp (FMBI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Media coverage about First Midwest Bancorp (NASDAQ:FMBI) has been trending somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. First Midwest Bancorp earned a news sentiment score of 0.06 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 45.6144382724963 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
- [By Max Byerly]
Get a free copy of the Zacks research report on First Midwest Bancorp (FMBI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Best Undervalued Stocks To Buy For 2019: Apricus Biosciences, Inc(APRI)
Advisors' Opinion:- [By Chris Lange]
Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA's review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.
- [By Paul Ausick]
Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.
- [By Alexander Bird]
Here are last week's top-performing penny stocks:
Penny Stock Current Share Price Last Week's Gain Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11% Nano Dimension (Nasdaq: NNDM) $2.61 75.11% Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84% CLPS Inc. (Nasdaq: CLPS) $9.72 71.15% NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33% Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98% Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82% Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70% Polymet Mining Corp. (NYSE: PLM) $1.01 31.13% Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%Many investors struggle with finding stocks with this sort of breakout potential because they don't know where to look.
- [By William Romov]
California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).
No comments:
Post a Comment